EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback